FindTrial
Sign In

CYP17A1 rs743572 polymorphism might contribute to endometriosis susceptibility: evidence from a case-control study

CYP17A1 rs743572 polymorphism might contribute to endometriosis susceptibility: evidence from a case-control study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014798
Enrollment
Unknown
Registered
2018-02-06
Start date
2011-02-01
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

case:endometriosis
control:healthy individual

Sponsors

Linyi central hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: endometriosis patients were according to the European society of human reproduction and embryology (ESHRE) guidelines

Exclusion criteria

Exclusion criteria: had no other cancers or cardiovascular diseases

Design outcomes

Primary

MeasureTime frame
genotype;—

Countries

China

Contacts

Public ContactQiang Fu

Linyi Central Hospital

jio3ogr@126.com+86 14763482294

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026